| Hint | Answer | % Correct |
|---|---|---|
| Proton pump inhibitor (PPI), used for GERD and peptic ulcer disease | Omeprazole | 88%
|
| Opioid medication used for analgesia; addiction risk | Oxycodone | 88%
|
| Atypical antipsychotic agent | Olanzapine | 75%
|
| Anti-emetic medication, often given to treat nausea in the hospital | Ondansetron | 75%
|
| Angiotensin receptor blocker (ARB), used for hypertension | Olmesartan | 63%
|
| Anti-seizure medication; structural derivative of carbamazepine | Oxcarbazepine | 63%
|
| Fluoroquinolone antibiotic, also available as eye or ear drops | Ofloxacin | 50%
|
| Lipase inhibitor used for weight loss | Orlistat | 38%
|
| Anti-influenza drug that is a neuraminidase inhibitor | Oseltamivir | 38%
|
| Another monoclonal antibody targeting CD20, used for multiple sclerosis | Ocrelizumab | 25%
|
| Anti-histamine, used for allergic rhinitis and allergic conjunctivitis | Olopatadine | 25%
|
| Monoclonal antibody targeting IgE, used for severe asthma | Omalizumab | 25%
|
| Antibiotic of the penicillin (β-lactam) class; covers Staphylococcus aureus | Oxacillin | 25%
|
| Anti-muscarinic agent, used for overactive bladder (urge incontinence) | Oxybutynin | 25%
|
| Sympathomimetic used in nasal spray as vasoconstrictor and decongestant | Oxymetazoline | 25%
|
| Monoclonal antibody targeting CD20, used for chronic lymphocytic leukemia | Obinutuzumab | 13%
|
| Somatostatin analog, used for acromegaly and carcinoid syndrome | Octreotide | 13%
|
| PARP inhibitor used for breast cancer and ovarian cancer | Olaparib | 13%
|
| EGFR inhibitor used for lung cancer | Osimertinib | 13%
|
| Platinum-based chemotherapy, used for colorectal cancer | Oxaliplatin | 13%
|